Last updated: Oct 6, 2026, 12:00 AM

Kiniksa Pharmaceuticals Ltd Exchange (NASDAQ, USD)

KNSA

77.09
-1.12 (-1.48%)
HealthcareDrug Manufacturers - Specialty & Generic
Invest Today
Invest Today
1 year return (CAGR)
92.44%
3 year return (CAGR)
65.93%
5 year return (CAGR)
45.08%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
3.60B
Price/Sales
4.28
Ent value
3.67B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
44.67
PEG
-
Forward P/E
46.13
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open76.55
Daily high76.55
Daily low73.77
Daily Volume651K
All-time high80.92
1y analyst estimate98.00
Beta0.09
EPS (TTM)0.97
Dividend per share0.00
Ex-div date-
Next earnings date3 Mar 2026

Ready to capitalize on Kiniksa Pharmaceuticals Ltd's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
KNSAS&P500
Current price drop from All-time high-4.73%-1.79%
Highest price drop-83.06%-56.47%
Date of highest drop18 Oct 20199 Mar 2009
Avg drop from high-38.88%-10.67%
Avg time to new high33 days12 days
Max time to new high1724 days1805 days